Jennifer Richmond1, Olive M Mbah2, Sofia Z Dard3, Lauren C Jordan2, Katherine S Cools4, Cleo A Samuel5, Jalaal M Khan6, Matthew A Manning6. 1. University of North Carolina at Chapel Hill Gillings School of Global Public Health, Department of Health Behavior, 135 Dauer Drive, 302 Rosenau Hall, CB #7440, Chapel Hill, NC 27599-7440, USA; American Institutes for Research, Research and Evaluation, Domestic, 100 Europa Drive, Suite 315, Chapel Hill, NC 27517, USA. Electronic address: Jennifer_Richmond@unc.edu. 2. University of North Carolina at Chapel Hill Gillings School of Global Public Health, Department of Health Policy and Management, 135 Dauer Drive, 1101 McGavran-Greenberg Hall, CB 741, Chapel Hill, NC, 27599-7411, USA. 3. University of North Carolina at Chapel Hill, North Carolina Translational and Clinical Sciences Institute, Brinkhous-Bullitt Building, 2nd Floor CB 7064, 160 N. Medical Drive, Chapel Hill, NC 27599-7064, USA. 4. University of North Carolina at Chapel Hill Gillings School of Global Public Health, Department of Health Policy and Management, 135 Dauer Drive, 1101 McGavran-Greenberg Hall, CB 741, Chapel Hill, NC, 27599-7411, USA; University of North Carolina School of Medicine, Department of Surgery, 4001 Burnett-Womack Building, CB #7050, Chapel Hill, NC 27599-7050, USA. 5. University of North Carolina at Chapel Hill Gillings School of Global Public Health, Department of Health Policy and Management, 135 Dauer Drive, 1101 McGavran-Greenberg Hall, CB 741, Chapel Hill, NC, 27599-7411, USA; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27514, USA. 6. Cone Health Cancer Center, Radiation Oncology, 2400 W. Friendly Avenue, Greensboro, NC 27403, USA.
Abstract
BACKGROUND: Lung cancer is the leading cause of cancer death in the US, and significant racial disparities exist in lung cancer outcomes. For example, Black men experience higher lung cancer incidence and mortality rates than their White counterparts. New screening recommendations for low-dose computed tomography (LDCT) promote earlier detection of lung cancer in at-risk populations and can potentially help mitigate racial disparities in lung cancer mortality if administered equitably. Yet, little is known about the extent of racial differences in uptake of LDCT. OBJECTIVE: To evaluate potential racial disparities in LDCT screening in a large community-based cancer center in central North Carolina. METHODS: We conducted a retrospective study of the initial patients undergoing LDCT in a community-based cancer center (n = 262). We used the Pearson chi-squared test to assess potential racial disparities in LDCT screening. RESULTS: Study results suggest that Black patients may be less likely than White patients to receive LDCT screening when eligible (χ2 = 51.41, p < 0.0001). CONCLUSION: Collaboration among healthcare providers, researchers, and decision makers is needed to promote LDCT equity.
BACKGROUND:Lung cancer is the leading cause of cancer death in the US, and significant racial disparities exist in lung cancer outcomes. For example, Black men experience higher lung cancer incidence and mortality rates than their White counterparts. New screening recommendations for low-dose computed tomography (LDCT) promote earlier detection of lung cancer in at-risk populations and can potentially help mitigate racial disparities in lung cancer mortality if administered equitably. Yet, little is known about the extent of racial differences in uptake of LDCT. OBJECTIVE: To evaluate potential racial disparities in LDCT screening in a large community-based cancer center in central North Carolina. METHODS: We conducted a retrospective study of the initial patients undergoing LDCT in a community-based cancer center (n = 262). We used the Pearson chi-squared test to assess potential racial disparities in LDCT screening. RESULTS: Study results suggest that Black patients may be less likely than White patients to receive LDCT screening when eligible (χ2 = 51.41, p < 0.0001). CONCLUSION: Collaboration among healthcare providers, researchers, and decision makers is needed to promote LDCT equity.
Authors: Yukiko Kunitomo; Brett Bade; Craig G Gunderson; Kathleen M Akgün; Alexandria Brackett; Lynn Tanoue; Lori A Bastian Journal: J Gen Intern Med Date: 2022-07-15 Impact factor: 6.473
Authors: Jessica M Powers; Emily L Zale; Alexa G Deyo; Dana Rubenstein; Ellen L Terry; Bryan W Heckman; Joseph W Ditre Journal: J Racial Ethn Health Disparities Date: 2022-09-28
Authors: Denalee M O'Malley; Catherine M Alfano; Michelle Doose; Anita Y Kinney; Simon J Craddock Lee; Larissa Nekhlyudov; Paul Duberstein; Shawna V Hudson Journal: Transl Behav Med Date: 2021-11-30 Impact factor: 3.046
Authors: Elizabeth G Bouchard; Frances G Saad-Harfouche; Nikia Clark; Jomary Colon; Susan A LaValley; Mary Reid; Kristopher Attwood; Maansi Bansal-Travers; Kathryn Glaser Journal: J Cancer Educ Date: 2022-07-15 Impact factor: 1.771
Authors: Karriem S Watson; Leilah D Siegel; Vida A Henderson; Marcus Murray; I Beverly Chukwudozie; David Odell; James Stinson; Ose Ituah; Josef Ben Levi; Marian L Fitzgibbon; Sage Kim; Phoenix Matthews Journal: Am J Mens Health Date: 2020 Sep-Oct